Oncology News

Despite the long-established prevalence of 3D printing in orthopedic oncology, some orthopedic surgeons said recent technological improvements and novel applications of the tool may help change the way cancerous tumors are treated.

When applying new technology to any medical intervention, we should begin with the end in mind and ask what problem are we trying to solve and could this new technology cause more harm than current solutions.

For the 14th straight year, Hospital for Special Surgery has been named the top hospital in the United States for orthopedic care, according to the latest U.S. News & World Report “Best Hospitals” survey.

Massive osteolytic metastases in the periacetabular regions are clinical dilemmas.

Healio celebrates Mental Health Awareness Month with a focus on physician burnout, an emerging public health crisis among orthopedic physicians and providers.

LAS VEGAS — Results showed tranexamic acid may reduce blood loss and transfusion requirements postoperatively among patients who underwent hemiarthroplasty or total hip arthroplasty for pathologic hip fractures.

LAS VEGAS — Although pediatric patients undergoing endoprosthetic reconstruction for primary bone tumors had better functional outcomes than adults throughout treatment, results showed both groups had similar overall improvement at 1 year.

LAS VEGAS — Results presented at the American Academy of Orthopaedic Surgeons Annual Meeting showed patients who were prescribed anabolic bone-forming medications were not at increased risk for developing primary bone neoplasm.

LAS VEGAS — In this video from the American Academy of Orthopaedic Surgeons Annual Meeting, Nicola Fabbri, MD, discussed the use of tranexamic acid for patients with metastatic cancer who undergo total hip arthroplasty or hemiarthroplasty.

Michelle Ghert, MD, FRCSC, received the Kappa Delta Ann Doner Vaughn Award on behalf of the Prophylactic Antibiotic Regimens in Tumor Surgery investigators at the American Academy of Orthopaedic Surgeons Annual Meeting.